FDA approves second gene therapy, Zolgensma, to treat spinal muscular atrophy in infants

FDA approves second gene therapy, Zolgensma, to treat spinal muscular atrophy in infants

At $2,125,000, it is the most expensive drug in the world

  • 0 Likes

  • 0 Comments